Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic pharmacologic therapy of ARDS

J J Komara1, P Perez-Trepichio, H P Wiedemann

  • 1Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Ohio, USA.

Respiratory Care Clinics of North America
|January 9, 1999
PubMed
Summary

Despite advances in understanding acute lung injury, no pharmacologic treatments for Acute Respiratory Distress Syndrome (ARDS) have been clinically validated. Ongoing research aims to develop effective therapies for ARDS patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary desmosine as a biomarker in acute lung injury.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2006
Same author

Major histocompatibility locus genetic markers of beryllium sensitization and disease.

The European respiratory journal·2001
Same author

Listeria monocytogenes tricuspid valve endocarditis with septic pulmonary emboli in a liver transplant recipient.

Transplant infectious disease : an official journal of the Transplantation Society·2001
Same author

Coccidioidomycosis in non-endemic areas: a case series.

Respiratory medicine·2001
Same author

A study of consecutive autopsies in a medical ICU : a comparison of clinical cause of death and autopsy diagnosis.

Chest·2001
Same author

Partial liquid ventilation for acute respiratory distress syndrome.

Clinics in chest medicine·2000

Area of Science:

  • Pulmonary Medicine
  • Critical Care Medicine
  • Pharmacology

Background:

  • Recent decades have seen significant progress in understanding the pathophysiology of acute lung injury.
  • This has spurred the development of novel pharmacologic strategies for Acute Respiratory Distress Syndrome (ARDS).

Purpose of the Study:

  • To review the current status of pharmacologic approaches for ARDS prevention and management.
  • To highlight the gap between promising preclinical data and clinical trial validation.

Main Methods:

  • Review of in vitro and animal model studies.
  • Analysis of clinical trial outcomes for ARDS pharmacotherapies.

Main Results:

  • Numerous pharmacologic strategies show promise based on preclinical data.
  • However, no specific pharmacologic approach for ARDS has been conclusively validated in clinical trials to date.

Conclusions:

  • While basic and clinical research are actively pursuing new ARDS therapies, effective treatments remain elusive.
  • Continued investigation is crucial for developing clinically applicable interventions for ARDS management.

Related Experiment Videos